Atrioventricular block (AVB) is a significant form of bradyarrhythmia observed in pediatric patients, categorized broadly into congenital and acquired types. Recent genomic studies are focusing on pinpointing specific genetic loci responsible for the onset and progression of this cardiac conduction disorder in children.
Identifying these underlying genetic factors plays a critical role in advancing early diagnosis, refining risk assessment, and guiding clinical management strategies. By uncovering the specific genes and variants involved, researchers aim to improve therapeutic approaches and outcomes for young patients affected by AVB.
Source Attribution: Article content originally reported by Pan; Zhenhui; Zhao; Wanling; Liu; Fuqiang; Li; Yifei. Read original story coverage on Pan; Zhenhui; Zhao; Wanling; Liu; Fuqiang; Li; Yifei →
